Stockreport

Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study

Vaxart, Inc.  (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
PDF Both norovirus vaccines induced substantial immune responses with no indicationof immunological interference when administered concurrently Phase 2-ready oral norovirus [Read more]